Survival analysis with uncertain endpoints using an internal validation subsample

作者: Jarcy Zee

DOI:

关键词:

摘要: When a true survival endpoint cannot be assessed for some subjects, an alternative that measures the with error may collected, which often occurs when is too invasive or costly to obtain. We develop nonparametric and semiparametric estimated likelihood functions incorporate both uncertain endpoints available all participants only subset of participants. propose maximum estimators discrete function time hazard ratio representing effect binary continuous covariate assuming proportional hazards model. show proposed are consistent asymptotically normal analytical forms variance estimators. Through extensive simulations, we also have little bias compared naA ve estimator, uses endpoints, more efficient moderate missingness complete-case endpoints. illustrate method by estimating risk developing Alzheimer's disease using data from Disease Neuroimaging Initiative. Using our optimal study design strategies compare across treatment groups new trial these characteristics. demonstrate how calculate number events in validation set desired power simulated baseline distribution event, size, correlation between outcomes, proportion outcomes missing can pilot studies. sample size formula does not depend on event calculated matches well simulation based results. results Ginkgo Evaluation Memory study, would need observed studies comparing development among those without antihypertensive use, as total subjects recruited trials. Degree Type Dissertation Name Doctor Philosophy (PhD) Graduate Group Epidemiology & Biostatistics First Advisor Sharon X. Xie

参考文章(33)
Raji Balasubramanian, Stephen W. Lagakos, Estimation of the Timing of Perinatal Transmission of HIV Biometrics. ,vol. 57, pp. 1048- 1058 ,(2001) , 10.1111/J.0006-341X.2001.01048.X
Bradley Efron, The Efficiency of Cox's Likelihood Function for Censored Data Journal of the American Statistical Association. ,vol. 72, pp. 557- 565 ,(1977) , 10.1080/01621459.1977.10480613
David A. Schoenfeld, Sample-size formula for the proportional-hazards regression model. Biometrics. ,vol. 39, pp. 499- 503 ,(1983) , 10.2307/2531021
Joanna H. Shih, Sample size calculation for complex clinical trials with survival endpoints Controlled Clinical Trials. ,vol. 16, pp. 395- 407 ,(1995) , 10.1016/S0197-2456(95)00132-8
Michelle Mielke, Prashanthi Vemuri, Walter Rocca, Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences Clinical Epidemiology. ,vol. 6, pp. 37- 48 ,(2014) , 10.2147/CLEP.S37929
Kjeld Andersen, Lenore J Launer, Michael E Dewey, L Letenneur, A Ott, JRM Copeland, J-F Dartigues, P Kragh–Sorensen, M Baldereschi, C Brayne, A Lobo, JM Martinez–Lage, T Stijnen, A Hofman, EURODEM Incidence Research Group, Gender differences in the incidence of AD and vascular dementia The EURODEM Studies Neurology. ,vol. 53, pp. 1992- 1992 ,(1999) , 10.1212/WNL.53.9.1992
Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Robert C. Green, Danielle Harvey, Clifford R. Jack, William Jagust, Enchi Liu, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Mark E. Schmidt, Leslie Shaw, Li Shen, Judith A. Siuciak, Holly Soares, Arthur W. Toga, John Q. Trojanowski, , The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Alzheimers & Dementia. ,vol. 9, ,(2012) , 10.1016/J.JALZ.2013.05.1769
Leslie M Shaw, Hugo Vanderstichele, Malgorzata Knapik‐Czajka, Christopher M Clark, Paul S Aisen, Ronald C Petersen, Kaj Blennow, Holly Soares, Adam Simon, Piotr Lewczuk, Robert Dean, Eric Siemers, William Potter, Virginia M‐Y Lee, John Q Trojanowski, Alzheimer's Disease Neuroimaging Initiative, Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology. ,vol. 65, pp. 403- 413 ,(2009) , 10.1002/ANA.21610